{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:00:26Z","timestamp":1772164826808,"version":"3.50.1"},"reference-count":46,"publisher":"American Association for Cancer Research (AACR)","issue":"7","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>This study examined racial and ethnic disparities in the use of analgesic and psychiatric medications during end-of-life care among Medicare beneficiaries with advanced-stage colorectal cancer. Using the Surveillance, Epidemiology, and End Results\u2013Medicare\u2013linked database from 2005 to 2017, we identified 28,212 patients with stage IV colorectal cancer who died within 1 year of diagnosis. Multivariable logistic regression models were used to assess differences in medication use by race and ethnicity. Compared with non-Hispanic White patients, Black patients had significantly lower odds of opioid use [adjusted OR (aOR) = 0.86; 95% confidence interval (CI), 0.80\u20130.93] and overall analgesic use, whereas Hispanic patients had higher use of opioids (aOR = 1.12; 95% CI, 1.03\u20131.22) and non-opioid analgesics (aOR = 1.22; 95% CI, 1.06\u20131.40). Asian patients had increased non-opioid use (aOR = 1.71; 95% CI, 1.44\u20132.03) and decreased skeletal muscle relaxant use (aOR = 0.59; 95% CI, 0.43\u20130.82). Across all minority groups, psychiatric medication use was consistently lower than in non-Hispanic White patients. These disparities persisted after adjusting for demographic, clinical, and socioeconomic factors. Findings highlight the urgent need for equitable, culturally responsive symptom management strategies to improve the quality of end-of-life care in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>We identified significant disparities in the use of analgesic and psychiatric medications among patients with advanced-stage colorectal cancer. Our findings are significant given the emerging importance of symptom management on health-related quality of life and survival. Future research is needed to understand causal factors, their influence on patient-reported outcomes such as symptom relief, and the development of strategies to close these medication use gaps.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0164","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T07:14:02Z","timestamp":1750317242000},"page":"1095-1101","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Racial Disparities in Analgesic and Psychiatric Medication Use During End-Of-Life Care in Advanced-Stage Colorectal Cancer: A Retrospective Cohort Study"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0033-4508","authenticated-orcid":false,"given":"John M.","family":"Allen","sequence":"first","affiliation":[{"name":"1Department of Pharmacy Practice, Purdue University College of Pharmacy, West Lafayette, Indiana."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0727-6303","authenticated-orcid":false,"given":"Olga M.","family":"Trejos Kweyete","sequence":"additional","affiliation":[{"name":"2Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Orlando, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0587-4105","authenticated-orcid":false,"given":"Yi","family":"Guo","sequence":"additional","affiliation":[{"name":"3Department of Health Outcomes & Biomedical Informatics, University of Florida College of Medicine, Gainesville, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2238-5429","authenticated-orcid":false,"given":"Jiang","family":"Bian","sequence":"additional","affiliation":[{"name":"4Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2804-0985","authenticated-orcid":false,"given":"Xiwei","family":"Lou","sequence":"additional","affiliation":[{"name":"3Department of Health Outcomes & Biomedical Informatics, University of Florida College of Medicine, Gainesville, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4886-3169","authenticated-orcid":false,"given":"Sherise C.","family":"Rogers","sequence":"additional","affiliation":[{"name":"5Division of Hematology & Oncology, University of Florida College of Medicine, Gainesville, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1255-0811","authenticated-orcid":false,"given":"Lisa","family":"Scarton","sequence":"additional","affiliation":[{"name":"6Department of Family, Community, and Health Systems Science, University of Florida College of Nursing, Gainesville, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2207-9552","authenticated-orcid":false,"given":"David L.","family":"DeRemer","sequence":"additional","affiliation":[{"name":"7Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3954-8933","authenticated-orcid":false,"given":"Diana J.","family":"Wilkie","sequence":"additional","affiliation":[{"name":"8Department of Biobehavioral Nursing Science, University of Florida College of Nursing, Gainesville, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"2025070723504964200_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3322\/caac.21772","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"2025070723504964200_bib2","doi-asserted-by":"crossref","first-page":"103122","DOI":"10.1016\/j.critrevonc.2020.103122","article-title":"Management of pain in colorectal cancer patients","volume":"157","author":"Zieli\u0144ska","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"2025070723504964200_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jncimonographs\/lgh014","article-title":"Prevalence of depression in patients with cancer","volume":"32","author":"Massie","year":"2004","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2025070723504964200_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N Engl J Med"},{"key":"2025070723504964200_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.2017.7156","article-title":"Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment","volume":"318","author":"Basch","year":"2017","journal-title":"JAMA"},{"key":"2025070723504964200_bib6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.2018.18085","article-title":"Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer","volume":"321","author":"Denis","year":"2019","journal-title":"JAMA"},{"key":"2025070723504964200_bib7","doi-asserted-by":"crossref","first-page":"10732748231185047","DOI":"10.1177\/10732748231185047","article-title":"Baseline quality of life is a strong and independent prognostic factor for overall survival in metastatic colorectal cancer","volume":"30","author":"McGarrah","year":"2023","journal-title":"Cancer Control"},{"key":"2025070723504964200_bib8","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1007\/s00520-015-2698-5","article-title":"Chemotherapy interruptions in relation to symptom severity in advanced breast cancer","volume":"23","author":"Wyatt","year":"2015","journal-title":"Support Care Cancer"},{"key":"2025070723504964200_bib9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ijrobp.2016.01.043","article-title":"Radiation therapy noncompliance and clinical outcomes in an urban academic cancer center","volume":"95","author":"Ohri","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025070723504964200_bib10","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1200\/JCO.2007.14.8452","article-title":"Racial and ethnic differences in advance care planning among patients with cancer: impact of terminal illness acknowledgment, religiousness, and treatment preferences","volume":"26","author":"Smith","year":"2008","journal-title":"J Clin Oncol"},{"key":"2025070723504964200_bib11","doi-asserted-by":"crossref","first-page":"e1917995","DOI":"10.1001\/jamanetworkopen.2019.17995","article-title":"Association of race and socioeconomic status with colorectal cancer screening, colorectal cancer risk, and mortality in southern US adults","volume":"2","author":"Warren Andersen","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2025070723504964200_bib12","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/jnci\/djt318","article-title":"Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer","volume":"105","author":"Simpson","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"2025070723504964200_bib13","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1200\/JOP.19.00767","article-title":"Racial disparities in health care utilization at the end of life among New Jersey medicaid beneficiaries with advanced cancer","volume":"16","author":"Yang","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"2025070723504964200_bib14","doi-asserted-by":"crossref","first-page":"e2014639","DOI":"10.1001\/jamanetworkopen.2020.14639","article-title":"Evaluation of racial disparities in hospice use and end-of-life treatment intensity in the REGARDS cohort","volume":"3","author":"Ornstein","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025070723504964200_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.2016.70.1474","article-title":"Integration of palliative care into standard oncology care: American society of clinical oncology clinical practice guideline update","volume":"35","author":"Ferrell","year":"2017","journal-title":"J Clin Oncol"},{"key":"2025070723504964200_bib16","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/neuonc\/noaa054","article-title":"Racial disparities in supportive medication use among older patients with brain metastases: a population-based analysis","volume":"22","author":"Lamba","year":"2020","journal-title":"Neuro Oncol"},{"key":"2025070723504964200_bib17","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1200\/JCO.2015.64.8162","article-title":"Investigation of racial disparities in early supportive medication use and end-of-life care among medicare beneficiaries with stage IV breast cancer","volume":"34","author":"Check","year":"2016","journal-title":"J Clin Oncol"},{"key":"2025070723504964200_bib18","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1158\/1055-9965.EPI-23-0251","article-title":"Unraveling racial disparities in supportive care medication use among end-of-life pancreatic cancer patients: focus on pain management and psychiatric therapies","volume":"32","author":"Allen","year":"2023","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025070723504964200_bib19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"2025070723504964200_bib20","article-title":"CMS cell size suppression policy","author":"US Department of Health and Human Services","year":"2020"},{"key":"2025070723504964200_bib21","article-title":"Committee on understanding and eliminating racial and ethnic disparities in health care","volume-title":"Unequal treatment: confronting racial and ethnic disparities in health care","author":"Institute of Medicine (US)","year":"2003"},{"key":"2025070723504964200_bib22","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/j.1475-6773.2006.00583.x","article-title":"Implementing the Institute of Medicine definition of disparities: an application to mental health care","volume":"41","author":"McGuire","year":"2006","journal-title":"Health Serv Res"},{"key":"2025070723504964200_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrc747","article-title":"Molecular mechanisms of cancer pain","volume":"2","author":"Mantyh","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"2025070723504964200_bib24","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1158\/1078-0432.CCR-15-0586","article-title":"Genome-wide association studies for taxane-induced peripheral neuropathy in ECOG-5103 and ECOG-1199","volume":"21","author":"Schneider","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2025070723504964200_bib25","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1002\/cncr.26622","article-title":"Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults","volume":"118","author":"Mack","year":"2012","journal-title":"Cancer"},{"key":"2025070723504964200_bib26","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1200\/JCO.22.01637","article-title":"Potential mediators of oxaliplatin-induced peripheral neuropathy from adjuvant therapy in stage III colon cancer: findings from CALGB (alliance)\/SWOG 80702","volume":"41","author":"Lee","year":"2023","journal-title":"J Clin Oncol"},{"key":"2025070723504964200_bib27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1163\/156856005774382760","article-title":"The kallikrein-kinin system: from mediator of inflammation to modulator of cardioprotection","volume":"12","author":"Sharma","year":"2005","journal-title":"Inflammopharmacology"},{"key":"2025070723504964200_bib28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12885-018-4260-6","article-title":"The kallikrein-Kinin system modulates the progression of colorectal liver metastases in a mouse model","volume":"18","author":"da Costa","year":"2018","journal-title":"BMC Cancer"},{"key":"2025070723504964200_bib29","doi-asserted-by":"crossref","first-page":"7916031","DOI":"10.1155\/2017\/7916031","article-title":"Lifestyle-related factors in the self-management of chemotherapy-induced peripheral neuropathy in colorectal cancer: a systematic review","volume":"2017","author":"Derksen","year":"2017","journal-title":"Evid Based Complement Alternat Med"},{"key":"2025070723504964200_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12906-017-1556-z","article-title":"Anti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppression","volume":"17","author":"Jung","year":"2017","journal-title":"BMC Complement Altern Med"},{"key":"2025070723504964200_bib31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1200\/EDBK_180469","article-title":"Pain and opioids in cancer care: benefits, risks, and alternatives","volume":"37","author":"Bennett","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2025070723504964200_bib32","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.2174\/1381612825666190717091230","article-title":"Comparison of the quality of life of cancer patients with pain treated with oral controlled-release morphine and oxycodone and transdermal buprenorphine and fentanyl","volume":"25","author":"Leppert","year":"2019","journal-title":"Curr Pharm Des"},{"key":"2025070723504964200_bib33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/bmjspcare-2020-002624","article-title":"State of the science: opioids and survival in cancer pain management","volume":"10","author":"Boland","year":"2020","journal-title":"BMJ Support Palliat Care"},{"key":"2025070723504964200_bib34","volume-title":"WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents","author":"World Health Organization","year":"2018"},{"key":"2025070723504964200_bib35","article-title":"Adult cancer pain (Version 2.2023)","author":"National Comprehensive Cancer Network"},{"key":"2025070723504964200_bib36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11606-017-4199-3","article-title":"Cultural issues in medication adherence: disparities and directions","volume":"33","author":"McQuaid","year":"2018","journal-title":"J Gen Intern Med"},{"key":"2025070723504964200_bib37","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.1634\/theoncologist.2019-0396","article-title":"Impact of onset of psychiatric disorders and psychiatric treatment on mortality among patients with cancer","volume":"25","author":"Lee","year":"2020","journal-title":"Oncologist"},{"key":"2025070723504964200_bib38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12939-023-01883-w","article-title":"Exploring the complexity and spectrum of racial\/ethnic disparities in colon cancer management","volume":"22","author":"Greenberg","year":"2023","journal-title":"Int J Equity Health"},{"key":"2025070723504964200_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/bs.acr.2021.02.007","article-title":"Racial and ethnic disparities in colorectal cancer incidence and mortality","volume":"151","author":"Carethers","year":"2021","journal-title":"Adv Cancer Res"},{"key":"2025070723504964200_bib40","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1200\/JCO.23.00539","article-title":"Racial disparities in receipt of guideline-concordant care for early-onset colorectal cancer in the United States","volume":"42","author":"Nogueira","year":"2024","journal-title":"J Clin Oncol"},{"key":"2025070723504964200_bib41","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00520-013-2049-3","article-title":"The persistence of symptom burden: symptom experience and quality of life of cancer patients across one year","volume":"22","author":"Deshields","year":"2014","journal-title":"Support Care Cancer"},{"key":"2025070723504964200_bib42","first-page":"89","article-title":"Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors","volume":"14","author":"Rawla","year":"2019","journal-title":"Prz Gastroenterol"},{"key":"2025070723504964200_bib43","article-title":"cancer stat facts: pancreatic cancer","author":"National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program"},{"key":"2025070723504964200_bib44","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1200\/JCO.22.01413","article-title":"Racial and ethnic disparities in opioid access and urine drug screening among older patients with poor-prognosis cancer near the end of life","volume":"41","author":"Enzinger","year":"2023","journal-title":"J Clin Oncol"},{"key":"2025070723504964200_bib45","article-title":"US Census Bureau current population reports, P60-274, Health insurance coverage in the United States: 2020","author":"Keisler-Starkey","year":"2021"},{"key":"2025070723504964200_bib46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10552-006-0089-4","article-title":"Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies","volume":"18","author":"Clegg","year":"2007","journal-title":"Cancer Causes Control"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0164\/3622587\/crc-25-0164.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/7\/1095\/3628238\/crc-25-0164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/7\/1095\/3628238\/crc-25-0164.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T23:50:59Z","timestamp":1751932259000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/7\/1095\/763431\/Racial-Disparities-in-Analgesic-and-Psychiatric"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0164","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7915889","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.29499020","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29499011","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29499014","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29499017","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}